Marcia Blackmoore, Chief Commercial OfficerIn Cell and gene therapies (CGT) manufacturing— particularly for autologous therapies where one batch often serves a single patient—on-time delivery and first-time-right execution are critical. L7 Informatics, Inc. is addressing this challenge through a data-first Enterprise Science Platform, L7|ESP.
When scientific data is spread across siloed systems, batch review and release are delayed, increasing operational complexity, risk and the time taken for treatment delivery. CGT manufacturing is further constrained by complex QC methods, manual process execution and variability in patient-derived starting material, all of which make scaling operations inherently difficult. L7|ESP, a unified, ontology-driven platform, orchestrates scientific data, workflows and operational processes across the CGT lifecycle.
By embedding ontologies at the point of data capture, the platform contextualizes data at source, eliminating the need to assemble it retrospectively across systems and creating a single source of truth. Organizations gain real-time visibility into batch and process performance, facilitating deeper process understanding and faster decision-making.
“Rather than layering additional systems into an already fragmented environment, L7|ESP creates a single scientific data fabric that connects people, processes, instruments and systems across the vein-to-vein lifecycle,” says Marcia Blackmoore, chief commercial officer.
Powering Seamless CGT Operations
How does unified data orchestration improve continuity across complex CGT operational processes?
Unlike standalone digital systems like LIMS or MES, which address specific functions, L7|ESP operates as an orchestration layer that unifies processes end-to-end rather than simply integrating existing systems. By enabling true enterprise-wide data continuity, it eliminates the need for manual batch record reconciliation and provides complete visibility into process variability. The platform also supports seamless integration with existing enterprise systems, bringing contextual consistency to legacy environments without any disruptive rip-and-replace.
For CGT organizations, the chain of identity and the chain of custody are mission-critical. L7|ESP embeds these controls directly into the data layer, along with batch, sample and process lineage, ensuring complete traceability so the right material reaches the right patient. For CGT leaders preparing INDs, BLAs or commercial inspections, the platform shifts regulatory readiness from a reactive process toward a more proactive capability by structuring data as it is generated.
Why is standardization of workflows important for scaling CGT manufacturing operations effectively?
Biotech companies preparing for Phase II expansion often face fragmented systems across translational science, process development, QC, and GMP manufacturing. This results in disconnected systems and spreadsheets, slow deviation investigations, manual tech transfer to a CDMO, and inconsistent metadata across patient lots.
Protocol execution, batch records and QC processes are digitized and standardized, reducing variability and enhancing reproducibility across sites. This coordination becomes critical during tech transfer, where inconsistencies between development and manufacturing environments introduce delays, rework and risk. With harmonized data and workflows, organizations can accelerate transfer to CDMOs and improve the chances of first-time-right execution.
-
Rather than layering additional systems into an already fragmented environment, L7|ESP creates a single scientific data fabric that connects people, processes, instruments and systems across the vein-to-vein lifecycle.
Biotech companies preparing for Phase II expansion often face fragmented systems across translational science, process development, QC, and GMP manufacturing. This results in disconnected systems and spreadsheets, slow deviation investigations, manual tech transfer to a CDMO, and inconsistent metadata across patient lots.
L7|ESP addresses these challenges by unifying all workflows. Digital batch templates standardize execution, while real-time visibility into batch and process data improves operational oversight. Structured datasets strengthen comparability and support CMC readiness.
The result is shorter batch review timelines, faster root-cause analysis and quicker operational decision-making during tech transfer. L7|ESP also boosts regulatory confidence and helps establish a scalable foundation to support clinical expansion and future commercialization.
Turning Data Foundations into Intelligent Operations
In what way does structured data enable predictive and adaptive capabilities in manufacturing?
L7|ESP is built on Industry 4.0 principles, structured as a progression from foundational data to increasingly intelligent operations. Having established a structured data layer, L7 Informatics is now focused on incorporating predictive and adaptive capabilities into the platform. The goal is to enable organizations to anticipate process deviations and self-optimize performance based on historic data.
This progression reflects the principle that predictive and adaptive capabilities depend on high-quality, structured data generated during execution.
As CGT transitions from breakthrough science to global scale, L7|ESP serves as a unified data backbone for organizations working to scale CGT manufacturing while enabling faster execution, safer delivery and more consistent outcomes for patients. These capabilities have contributed to L7 Informatics being recognized as the Top Life Sciences Scientific Data Management Platform.
Selecting a Unified Scientific Data Management Platform for Advanced Therapies
Advanced therapies have introduced a manufacturing and data challenge that differs sharply from traditional biologics. Each batch often corresponds to a single patient, leaving no room for delay or error. Timelines are compressed, variability is inherent in source material, and regulatory scrutiny extends across every step from collection to administration. In this environment, fragmented digital systems create friction rather than flexibility. When laboratory, manufacturing and quality systems operate independently, teams are forced into manual reconciliation, increasing review cycles and exposing the process to avoidable risk.
The core issue lies in how data is created and governed. Many organizations still assemble data retrospectively, pulling from disconnected systems after execution. This approach slows batch release, complicates compliance and introduces gaps in traceability. In patient-specific therapies, even minor inconsistencies can compromise the chain of identity or the chain of custody, directly affecting patient safety. The expectation has shifted toward capturing structured, contextualized data at the moment it is generated, ensuring that every action is recorded with clarity and continuity.
Complexity in quality control and manufacturing further compounds the problem. Processes remain labor-intensive, requiring highly skilled personnel to interpret results and manage variability. Scaling from research to commercial production becomes difficult when knowledge transfer depends on manual transcription or fragmented documentation. Delays during tech transfer or inconsistencies across sites can disrupt timelines and increase the likelihood of failed batches. A platform that standardizes data across development, quality and manufacturing environments reduces this burden, allowing teams to move from interpretation to execution more efficiently.
Regulatory readiness now depends less on documentation volume and more on data integrity. Structured, GxP-aligned data capture enables automated traceability, auditability and reporting. Instead of assembling submissions from disparate sources, organizations can draw directly from governed datasets that reflect real-time activity. This reduces compliance risk and shortens the path to regulatory milestones. It also supports faster decision-making during deviations, where historical context can inform corrective actions without delay.
The shift toward advanced analytics and predictive modeling places further emphasis on data quality. Artificial intelligence applications depend on consistent, well-structured inputs. Systems that treat data as an afterthought struggle to deliver meaningful insights, while those that embed context at the source create a foundation for predictive capability. Real-time visibility into batch performance, process trends, and site-level variation becomes possible only when data is unified across the lifecycle.
Within this landscape, L7 Informatics, Inc. presents a distinct approach through its enterprise science platform. It builds a centralized data layer that contextualizes information at the point of origin, connecting laboratory, manufacturing and quality workflows into a single environment. Its ontology-driven model establishes a consistent framework for structuring data, reducing the need for manual reconciliation and improving traceability across patient-specific processes.
The platform integrates existing systems while providing a unified view of operations, supporting faster tech transfer, stronger compliance alignment and improved decision-making. This foundation also positions organizations to adopt predictive analytics and adaptive process optimization as their data maturity advances, making it a strong choice for organizations managing complex, patient-centric therapies.
...Read more
Life Sciences Scientific Data Management Platform Info
Q1
What led L7 Informatics to be recognized among top life sciences scientific data management platform providers?
A unified approach to managing complex scientific workflows has positioned L7 Informatics as a leader in Life Sciences Scientific Data Management Platforms. Its core platform, L7|ESP®, consolidates fragmented systems such as LIMS, ELN and MES into a single environment, eliminating data silos and enabling end-to-end visibility. By connecting research, development and manufacturing processes through a shared data model, the company enables faster, more informed decision-making. This ability to unify operations across the scientific lifecycle underpins its recognition in Life Sciences Scientific Data Management Platforms.
Q2
How does L7 Informatics differentiate its approach to scientific data management?
A data orchestration model defines how L7 Informatics delivers Life Sciences Scientific Data Management Platforms. Rather than functioning as a standalone data repository, its platform contextualizes and structures data using a single unified model, making it AI-ready and interoperable across systems. Workflow orchestration capabilities allow users to design and automate scientific processes with low-code tools, ensuring flexibility without sacrificing control. This combination of structured data and process orchestration sets its Life Sciences Scientific Data Management Platforms apart.
Q3
How does L7 Informatics support organizations across research and manufacturing workflows?
End-to-end integration strengthens how L7 Informatics delivers Life Sciences Scientific Data Management Platforms. The platform connects laboratory instruments, third-party applications and enterprise systems into a cohesive ecosystem, capturing data from sample intake through manufacturing and quality operations. Built-in applications for scheduling, inventory, analytics and environmental monitoring ensure that users can manage complex workflows within one interface. This integrated support enhances the usability and effectiveness of its Life Sciences Scientific Data Management Platforms.
Q4
What value do L7 Informatics’ platforms bring to life sciences organizations?
Operational efficiency and data integrity define the value of L7 Informatics’ Life Sciences Scientific Data Management Platforms. By replacing disconnected point solutions with a unified system, organizations can reduce redundancy, improve compliance and accelerate development timelines. The platform’s ability to generate harmonized, structured data enables advanced analytics, AI and machine learning applications, supporting more accurate insights and better outcomes. These benefits make its Life Sciences Scientific Data Management Platforms highly impactful across the value chain.
Q5
What role do technology and innovation play in its platform?
Advanced architecture and continuous innovation drive L7 Informatics’ Life Sciences Scientific Data Management Platforms. The platform incorporates workflow automation, knowledge graphs and ontology-driven data modeling to ensure that data is both compliant and analytically valuable. Its cloud-native design and extensive integration capabilities support scalability and adaptability across evolving scientific needs. This strong technological foundation ensures that its Life Sciences Scientific Data Management Platforms remain future-ready.
Q6
Why is L7 Informatics relevant to current life sciences digital transformation needs?
The increasing complexity of data across research, clinical and manufacturing environments has made unified platforms essential, and L7 Informatics addresses this through its Life Sciences Scientific Data Management Platforms. Its ability to create a continuous digital thread across the entire lifecycle—from discovery to production—aligns with the industry’s shift toward automation, AI-driven insights and real-time decision-making. By enabling organizations to operate with connected, contextualized data, the company remains highly relevant to modern scientific and operational challenges.
